Mesoscale maladaptation in disease organoids
Open Access
- 1 June 2026
- journal article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 19 (6)
Abstract
In chronic diseases, multiple tissue components at a shared interface often deteriorate concurrently, and disease progression may depend on interactions among these failures rather than on any single defect. Multi-tissue organoid models can mimic disease-relevant pathology in vitro, but the field lacks a simple framework for comprehensive interrogation. Here, we propose mesoscale maladaptation as an operational concept for multi-tissue disease modelling, defined as a synergistic decline in interdependent functions that can occur between two or more tissue elements. To detect maladaptation, we introduce a stepwise workflow that identifies the failing tissue elements, defines directionality of potential interdependence between these elements and compares combined perturbations with single perturbations to evaluate synergistic decline. We apply this framework to intestinal neuromuscular, hepatic sinusoidal, blood–brain barrier and tumour–neural interfaces, but it can be extrapolated to other organs and systems. This framework will illuminate future directions for in vitro complex disease modelling by enriching biological insights to disentangle progressive pathology, shifting the focus from localised biological failures to concurrent multi-tissue failures that produce synergistic pathology.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP18H02800)
- Japan Society for the Promotion of Science (25H01051)
- Japan Society for the Promotion of Science (25K00152)
- Japan Society for the Promotion of Science (JRP20251503)
- Japan Agency for Medical Research and Development (JP20fk0210037,)
- Japan Agency for Medical Research and Development (JP20bm0704025)
- Japan Agency for Medical Research and Development (JP24bm1223006)
- Japan Agency for Medical Research and Development (JP21bm0404045)
- Japan Agency for Medical Research and Development (JP25gm1210012)
- Japan Agency for Medical Research and Development (JP26gm1610005)
- Japan Agency for Medical Research and Development (JP25bm1223006)
- Japan Agency for Medical Research and Development (JP26fk0210150)
- Japan Agency for Medical Research and Development (JP26fk0210167,)
- Japan Agency for Medical Research and Development (26ym0126177)
- Japan Agency for Medical Research and Development (26fk0210165)
- Japan Agency for Medical Research and Development (26bm1123064)
- Japan Agency for Medical Research and Development (26bk0104202)
- Moonshot Research and Development Program (JPMJMS2033)
- Moonshot Research and Development Program (JPMJMS2022-1112)
This publication has 31 references indexed in Scilit:
- Glioblastoma invasion into different organoid hosts reveals cell-intrinsic and proliferative migratory programsiScience, 2026
- Bridging single cells to organs: Mesoscale modules as fundamental units of tissue functionCell, 2025
- Microphysiological systems as a pillar of the Human Exposome ProjectJournal of Biological Chemistry, 2025
- Co-development of mesoderm and endoderm enables organotypic vascularization in lung and gut organoidsCell, 2025
- AI‐organoid integrated systems for biomedical studies and applicationsBioengineering & Translational Medicine, 2024
- AI-enabled organoids: Construction, analysis, and applicationBioactive Materials, 2024
- En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASHCell, 2022
- Modeling Patient-Derived Glioblastoma with Cerebral OrganoidsCell Reports, 2019
- Fusion of Regionally Specified hPSC-Derived Organoids Models Human Brain Development and Interneuron MigrationCell Stem Cell, 2017
- Modeling Development and Disease with OrganoidsCell, 2016